BIOMARKER FOR DIAGNOSING EACH SUBTYPE OF PERIPHERAL NEUROPATHY

WIPO Patent Application WO/2020/209469

A1

The present invention provides a method for providing information for predicting or diagnosing a risk of developing each subtype of peripheral neuropathy by using a combination of biomarkers; a composition for diagnosing each subtype; and a drug screening method for treating peripheral neuropathy using same. The method of the present invention measures an expression level of a biomarker to effectively provide information for predicting or diagnosing the risk of developing each subtype of peripheral neuropathy, and the diagnostic composition and kit of the present invention can diagnose specific subtypes of peripheral neuropathy with high accuracy.

JPH11253176	MURF
WO/2019/068355	BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES
WO/2012/055828	METHOD OF DETERMINING RISK OF ARRYTHMIA

PARK HWAN TAE (KR)
KIM JONG KUK (KR)
KIM YOUNG HEE (KR)
HAN JIN YOUNG (KR)
CHOI BYUNG OK (KR)
KIM YOUNG HYE (KR)

PCT/KR2019/016923

October 15, 2020

December 03, 2019

Click for automatic bibliography generation  

SUGENTECH INC (KR)

G01N33/68; G01N33/53

WO2011061304A1

2011-05-26

US20040209307A1	2004-10-21
KR101289134B1	2013-07-23

LIU, Z. ET AL.: "Specific marker expression and cell state of Schwann cells during culture in vitro", PLOS ONE, vol. 10, no. 4, 2015, pages 1 - 17, XP055503115, DOI: 10.1371/journal.pone.0123278
KIM, Y. H. ET AL.: "p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathies", ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 6, no. 7, 2 July 2019 (2019-07-02), pages 1292 - 1301, XP055748623

PLUS INTERNATIONAL IP LAW FIRM (KR)

View/Download PDF      PDF Help

Previous Patent: SMART DISASTER-PREVENTION SYSTEM FOR EARTHQUAKES AND HAZARDOUS AREA STRUCTURES

Next Patent: FLOATING BODY HAVING IMPROVED DURABILITY, AND FLOATING PHOTOVOLTAIC DEVICE USING SAME